BD Named a Top 100 Global Innovator by LexisNexis

2026 recognition underscores the strength of BD's innovation engine and its contributions to sustainable growth, margin expansion and competitive advantage

FRANKLIN LAKES, N.J. (March 6, 2026) - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it was named a Top 100 Global Innovator by LexisNexis for 2026. This is the fourth consecutive year that BD has been recognized. The distinction reflects the strength of BD's innovation portfolio and highlights the company's momentum in advancing technologies that support long-term growth and elevate the standard of care for healthcare providers and patients.

The LexisNexis Top 100 Global Innovators list evaluates companies based on improvements in patent quality rather than the number of patents filed. The analysis uses the Patent Asset Index methodology to measure the strength, influence and global relevance of patent assets across more than seventeen million global patent families. The 2026 list and accompanying Innovation Momentum report also examines global inventor collaboration trends and emerging innovation dynamics.

"Being named a Top Global Innovator validates the creativity and impact of our teams who are solving healthcare's toughest challenges through innovations that simplify and personalize patient care," said Elizabeth McCombs, executive vice president and chief technology officer at BD. "We have sharpened our focus by partnering closely with customers to advance innovative platforms and products that help their businesses thrive, improve patient outcomes, and deliver stronger returns to our shareholders."

BD's innovation strategy remains closely aligned with the company's long-term growth priorities. The company continues to advance platforms in burgeoning areas such as smart connected care, AI-enabled solutions, robotics and automation, medication management, and high growth therapeutic categories. These technology investments support BD's ability to expand in higher margin, higher growth segments and accelerate the company's evolution into the world's premier MedTech leader.

"Innovation can sometimes feel like an abstract concept that is hard to measure and even harder to improve," said Marco Richter, Senior Director of IP Analytics and Strategy for LexisNexis Intellectual Property Solutions. "Happily, patent portfolios provide a relevant and impactful gauge for evaluating innovation across companies across all industries, technologies, and sizes. LexisNexis® Patent Asset Index provides an objective apples-to-apples framework for analyzing innovation leadership based on changes in the strength of each company's patent assets, highlighting the companies who are driving innovation forward. The Top 100 Global Innovators have demonstrated their leadership in advancing the world's knowledge, while creating technologies and tools that will build a better world."

Recent progress includes meaningful advancements in digital health ecosystems, expanded automation capabilities in pharmacies and clinical settings, and continued development of platforms that improve efficiency, safety and treatment outcomes. These innovations contribute to the company's ability to drive margin expansion, strengthen its competitive differentiation and support consistent sustainable growth.

About BD
BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X @BDandCo or Instagram @becton_dickinson.